Mesh Versus Suture Repair for Umbilical Hernias (HUMP)
|Umbilical Hernia||Procedure: primary suture closure Device: mesh enforced closure|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Suture versus mesh repair in umbilical hernia patientsMasking: Participant, Investigator, Outcomes Assessor
Primary Purpose: Treatment
|Official Title:||Mesh Versus Suture Repair for Umbilical Hernias: a Double Blinded, Randomised Controlled Clinical Trial|
- hernia recurrence rate [ Time Frame: 24 months ]
- Post-operative morbidity and complications [ Time Frame: 3 months ]
|Study Start Date:||January 2006|
|Study Completion Date:||August 2015|
|Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
|Active Comparator: primary suture||
Procedure: primary suture closure
primary suture closure of hernia
|Active Comparator: mesh enforced closure||
Device: mesh enforced closure
mesh enforced closure of hernia
Purpose The purpose of the present study is to investigate whether or not the use of mesh is indicated in the repair of all size umbilical hernias as to reduce the rate of recurrence. This method is regularly used in umbilical hernia reconstruction although most surgeons repair small hernias using suture repair (fascia adaptation). Especially risk factors for hernia recurrence such as hernia size and BMI > 30 kg/m2 need to be evaluated and correlated to the method of hernia repair.
Study design Randomised controlled, double blinded, multi-centre trial. 300 consecutive patients with an umbilical hernia will be included in the study. Patients will be randomised in one of two groups of 150 patients each. Group 1 will include patients that will undergo primary (suture) repair; group 2 umbilical hernias will be repaired using a pre-peritoneal, flat polypropylene mesh in a tension free fashion.
Stratification will be utilized for the size of the hernia (1-2 cm or ≥2-4 cm) and the participating centre. Patients will visit the outpatient clinic after 2-3 weeks and after 3, 12 and 24 months.
The cumulative hernia recurrence rate during the 2-years follow-up period will be the primary outcome of the study. Complications, pain and QOL are secondary endpoints.
Statistical analysis All analyses will be performed according to the intention to treat principle and as specified in the protocol.
Financial support None.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00789230
|Studienzentrum der Deutschen Gesellschaft für Chirurgie|
|University of Witten/Herdecke|
|Erasmus University Medical Center|
|Rotterdam, Zuid Holland, Netherlands, 3015CN|
|Onze Lieve Vrouwe Gasthuis|
|Reinier de Graaf Gasthuis|
|Máxima Medisch Centrum|
|Principal Investigator:||J. Jeekel, MD, PhD||Erasmus Medical Center|
|Principal Investigator:||J.F. Lange, MD, PhD||Erasmus Medical Center|